Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck CEO Says ‘Worth Thinking About’ Bausch & Lomb Deal
Bloomberg
Tuesday, January 8, 2013 - 8:58am
tags:
Bausch & Lomb, Merck, Kenneth Frazier, M&A
Intarcia Says It’s in Partner Talks Beyond Diabetes Drugs
Bloomberg
Monday, January 7, 2013 - 7:06pm
tags:
Intarcia, diabetes, ITCA 650
Encouraging News for Tranzyme Pharma
Yahoo/Zacks.com
Monday, January 7, 2013 - 7:03pm
tags:
Bristol-Myers Squibb, Tranzyme, R&D
Bristol-Myers May Sell Experimental Migraine Drug
Bloomberg
Monday, January 7, 2013 - 7:00pm
tags:
migraines, Bristol-Myers Squibb, BMS-927711
Cancers Linked to HPV Rise in U.S. on Low Vaccine Use
Bloomberg
Monday, January 7, 2013 - 6:58pm
tags:
HPV, cervical cancer, Gardasil, Merck, GSK, Cervarix
Sanofi Buys Rolaids, Plans Product Relaunch in 2013
Motley Fool
Monday, January 7, 2013 - 6:53pm
tags:
Rolaids, Sanofi, M&A, OTC, antacids, JNJ
Big News for These 2 Diabetes Hopefuls
Motley Fool
Monday, January 7, 2013 - 6:52pm
tags:
diabetes, empagliflozin, Eli Lilly, Invokana, JNJ
Zogenix shares edge higher on 4Q sales report
Yahoo/AP
Monday, January 7, 2013 - 6:43pm
tags:
Zogenix, earnings
Neurocrine Biosciences: Elagolix-Channel Checks And Expert Opinion Reveal Small Market Size, Unfavorable Incentives
Seeking Alpha
Monday, January 7, 2013 - 1:03pm
tags:
Neurocrine Biosciences, Elagolix, Abbott, AbbVie
Merck Emerges As Top Funder Of Digital Health Start-Ups
Forbes
Monday, January 7, 2013 - 12:58pm
tags:
Merck
Illumina to buy Verinata Health for $350 mln plus milestone payments
Reuters
Monday, January 7, 2013 - 10:40am
tags:
M&A, Illumina, Verinata
Vivus obesity pill prescriptions jump 68 percent, shares rise
Reuters
Monday, January 7, 2013 - 10:39am
tags:
Vivus, obesity, Qsymia
Alkermes Aims for Psychiatric Drug That Won’t Pack on the Pounds
Xconomy
Monday, January 7, 2013 - 10:38am
tags:
Alkermes, Eli Lilly, schizophrenia, ALKS33, Zyprexa
Roche chairman says Illumina bid off the table: paper
Yahoo/Reuters
Monday, January 7, 2013 - 10:36am
tags:
Roche, M&A, Illumina
Pfizer And Endo Pay $50M To Settle Fraud Cases
Pharmalot
Monday, January 7, 2013 - 10:34am
tags:
Endo, Pfizer, Medicaid fraud
The Medicines Company Completes Acquisition of Incline Therapeutics, Inc.
Yahoo
Monday, January 7, 2013 - 10:31am
tags:
M&A, The Medicines Company, Incline Therapeutics
SciClone Provides Initial 2013 Financial Guidance
Yahoo
Monday, January 7, 2013 - 10:30am
tags:
SciClone
Why the Street Should Love Merck's Earnings
Motley Fool
Monday, January 7, 2013 - 10:27am
tags:
Merck, earnings
AbbVie's Shares Are More Appealing Than Abbott's Following The Spin-Off
Seeking Alpha
Monday, January 7, 2013 - 10:26am
tags:
Abbott Laboratories, AbbVie
Creative Destruction And The Pharmaceutical Industry
Seeking Alpha
Monday, January 7, 2013 - 10:26am
tags:
Genomic Health, Eli Lilly, Novartis, Pfizer, Teva

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.